Prelivia

GUDID 17540176050008

The Prelivia System is a portable transcutaneous muscle stimulation system intended to increase regional blood circulation at stimulated treatment areas, and to reduce the incidence and progression of pressure ulcers (bed sores) in individuals who are immobile due to their clinical condition. The system consists of a battery

Rehabtronics Inc

Physical therapy transcutaneous neuromuscular electrical stimulation system
Primary Device ID17540176050008
NIH Device Record Key1b1a6467-e5ac-4409-bf36-e02c63d7520c
Commercial Distribution StatusIn Commercial Distribution
Brand NamePrelivia
Version Model NumberPR-IES1
Company DUNS243936569
Company NameRehabtronics Inc
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usefalse
Lot Batchfalse
Serial Numbertrue
Manufacturing Datetrue
Expiration Datefalse
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptionfalse
OTC Over-The-Counterfalse

Device Identifiers

Device Issuing AgencyDevice ID
GS117540176050008 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

IPFStimulator, Muscle, Powered

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2021-10-11
Device Publish Date2021-10-01

On-Brand Devices [Prelivia]

17540176050008The Prelivia System is a portable transcutaneous muscle stimulation system intended to increase
17540176050091The Prelivia System is a portable transcutaneous muscle stimulation system intended to increase

Trademark Results [Prelivia]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PRELIVIA
PRELIVIA
79314983 not registered Live/Pending
Rehabtronics Inc.
2021-04-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.